Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Imatinib in Children with Chronic Myeloid Leukemia in Chronic Phase: Long-Term Results of the French National Phase IV Trial

Hélène Deutsch, MD, Andre Baruchel, Joelle Guilhot, PhD, Arnaud Petit, MD PhD, Thierry Leblanc, MD, Yves Bertrand, MD, Brigitte Nelken, MD, Catherine Paillard, MD PhD, Cécile Verite, MD, Yves Réguerre, MD, Francoise Mechinaud, MD FRACP, Francois Guilhot, MD, Frederic Millot

Blood (2019) 134 (Supplement_1): 4147.

https://doi.org/10.1182/blood-2019-124060

Published: 2019

Journal Articles

Clinical Predictors of Venous Thromboembolism during Therapy for Childhood Acute Lymphoblastic Leukemia

Marion K Mateos, MBBS FRACP, Toby N. Trahair, MBBS FRACP PhD, Chelsea Mayoh, BSc, Pasquale M Barbaro, MBBS FRACP FRCPA, Rosemary Sutton, BSc PhD, Tamas Revesz, MD PhDD.Sc FRACP FRCPA, Draga Barbaric, MBBS FRACP, Jodie Giles, Frank Alvaro, MBBS, FRACP, Francoise Mechinaud, MD FRACP, Daniel Catchpoole, BSc PhDFFSc(RCPA), Rishi S Kotecha, MB ChB FRACP PhD, Luciano Dalla-Pozza, MB BS FRACP, Glenn M Marshall, MBBS, MD FRACP

Blood (2016) 128 (22): 1182.

https://doi.org/10.1182/blood.V128.22.1182.1182

Published: 2016

Journal Articles

Analysis of a Global Registration Trial of the Efficacy and Safety of CTL019 in Pediatric and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)

Blood (2016) 128 (22): 221.

https://doi.org/10.1182/blood.V128.22.221.221

Published: 2016

Journal Articles

Building a Targeted Approach to Assess Risk of Anthracycline Induced Cardiomyopathy Amongst Paediatric Cancer Patients

Anne Tripaydonis, Lauren Craig, Louise E. Ludlow, Michael Cheung, Francoise Mechinaud, MD FRACP, David Ritchie, MD PhD, David Elliot, Rachel Conyers

Blood (2016) 128 (22): 5280.

https://doi.org/10.1182/blood.V128.22.5280.5280

Published: 2016

Journal Articles

Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study

Frédéric Millot, Joelle Guilhot, André Baruchel, Arnaud Petit, Yves Bertrand, Françoise Mazingue, Patrick Lutz, Cecile Vérité, Christian Berthou, Claire Galambrun, Nicolas Sirvent, Karima Yakouben, Claudine Schmitt, Virginie Gandemer, Yves Reguerre, Gérard Couillault, Françoise Mechinaud, Jean-Michel Cayuela

Blood (2014) 124 (15): 2408–2410.

https://doi.org/10.1182/blood-2014-05-578567

Published: 2014

Includes: Supplemental data

Journal Articles

Outcomes After a Sequential Clofarabine/Arac-C Chemotherapy Followed By Reduced-Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (allo-SCT) In Pediatrics Patients With JMML Or Primary/Relapsed Refractory AML: A Pilot Study

Grain Audrey, Anne Sirvent, Marion Strullu, Francoise Mechinaud, MD, Mohamad Mohty, MD, PhD, Patrice Chevallier, MD, PhD, Thierry Guillaume, MD, Fanny Rialland, M.D.

Blood (2013) 122 (21): 5460.

https://doi.org/10.1182/blood.V122.21.5460.5460

Published: 2013

Journal Articles

Interim Report of a Randomized, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Decitabine As an Epigenetic Priming Agent When Combined with Induction Chemotherapy in Pediatric Patients (pts) with Newly Diagnosed Acute Myelogenous Leukemia (AML)

Lia Gore, MD, Margaret E. Macy, M.D., Francoise Mechinaud, MD, Aru Narendran, MD, PhD, Frank Alvaro, MD, Carola A.S. Arndt, MD, Phillip Barnette, MD, Jessica Boklan, MD, Todd Cooper, DO, Laura Martin, MD, W Tcheng, MD, Peter Tarassoff, MD, Mark M Jones, MD, Soheil Meshinchi, MD, PhD, Robert J. Arceci, MD, PhD

Blood (2012) 120 (21): 1517.

https://doi.org/10.1182/blood.V120.21.1517.1517

Published: 2012

Journal Articles

Daunorubicin or Not During the Induction Treatment of Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): The Randomized Fralle 2000-A Protocol

Blood (2012) 120 (21): 135.

https://doi.org/10.1182/blood.V120.21.135.135

Published: 2012

Journal Articles

Dasatinib In Children and Adolescents with Relapsed or Refractory Leukemia: Results of the CA180018 Phase 1 Dose-Escalation Study of the Innovative Therapies for Children with Cancer (ITCC) Consortium

C. Michel Zwaan, Carmelo Rizzari, Francoise Mechinaud, Donna L Lancaster, MBChB, MRCPCH, Pamela R. Kearns, BSc, MBBCh, MRCP, PhD, Thomas Lehrnbecher, Vincent H. J. van der elden, H. Berna Beverloo, PhD, Monique L. den Boer, Rob Pieters, MD, PhD, Julie Rosenberg, Robert Herdlicka, Dominique Derreumaux, Shruti Agrawal, André Baruchel

Blood (2010) 116 (21): 2265.

https://doi.org/10.1182/blood.V116.21.2265.2265

Published: 2010

Journal Articles

Reduced-Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT) In Pediatric Patients Ineligible for Standard Myeloablative Conditioning.

M. Strullu, M.D., Fanny Rialland, M.D., Eolia Brissot, N. Corradini, M.D., Caroline Thomas, M.D., Francoise Mechinaud, MD, Mohamad Mohty

Blood (2010) 116 (21): 3478.

https://doi.org/10.1182/blood.V116.21.3478.3478

Published: 2010

Journal Articles

Infectious Complications After Unrelated Umbilical Cord Blood Transplantation (UCBT) in Adult Patients with Hematological Malignancies.

Xavier Cahu, Fanny Rialland, Cyrille Touzeau, Patrice Chevallier, MD, Thierry Guillaume, Jacques Delaunay, Sameh Ayari, Viviane Dubruille, Steven Le Gouill, MD, PhD, Beatrice Mahe, Thomas Gastinne, Nicolas Blin, Beatrice Saulquin, Jean-Luc Harousseau, Philippe Moreau, MD, Francoise Mechinaud, Mohamad Mohty, MD, PhD

Blood (2009) 114 (22): 1142.

https://doi.org/10.1182/blood.V114.22.1142.1142

Published: 2009

Journal Articles

Excellent Prognosis of Children with ETV6-RUNX1 Positive (+) Acute Lymphoblastic Leukemia (ALL) in the FRALLE 2000 Protocol.

Virginie Gandemer, MD, Marie-Françoise Auclerc, MD, Arnaud Petit, MD, Benoît Brethon, MD, Paola Ballerini, Gerard Michel, MD, PhD, Yves Perel, MD, PhD, Anne Auvrignon, MD, Francoise Mechinaud, Claudine Schmitt, Pascale Schneider, Christiane Vermylen, Odile Lejars, MD, Thierry Leblanc, MD, Jean Gabert, MD, PhD, Elizabeth Macintyre, MD, PhD, Jean-Michel Cayuela, PharmD, PhD, Guy Leverger, MD, Andre Baruchel, MD

Blood (2009) 114 (22): 1628.

https://doi.org/10.1182/blood.V114.22.1628.1628

Published: 2009

Journal Articles

Escalated lymphodepletion Followed by Donor Lymphocyte Infusion (DLI) can Induce a Graft-Versus-Host Response without Overwhelming Toxicity.

Thierry Guillaume, Patrice Chevallier, Sameh Ayari, Jacques Delaunay, Francoise Mechinaud, Philippe Moreau, Mohamad Mohty

Blood (2009) 114 (22): 3033.

https://doi.org/10.1182/blood.V114.22.3033.3033

Published: 2009

Journal Articles

Dasatinib in Children and Adolescents with Relapsed or Refractory Leukemia: Interim Results of the CA180-018 Phase I Study from the ITCC Consortium.

C. Michel Zwaan, MD, PhD, Carmelo Rizzari, Vincent H.J. van der Velden, Berna Beverloo, M. L. den Boer, Andre Baruchel, Francoise Mechinaud, Donna Lancaster, Yousif Matloub, Dominique Derreumaux, Rob Pieters, Pamela Kearns

Blood (2008) 112 (11): 3241.

https://doi.org/10.1182/blood.V112.11.3241.3241

Published: 2008

Journal Articles

Prior Treatment with Chemotherapy Associated to Gemtuzumab Ozogamicin (GO) Does Not Increase the Risk of Veno-Occlusive Disease (VOD) after Allogeneic Stem Cell Transplantation (all-SCT).

Patrice Chevallier, Thomas Prebet, MD, Pascal Turlure, Mathilde Hunault, Stephane Vigouroux, Catherine Faucher, Thierry Guillaume, Francoise Mechinaud, Sameh Ayari, Jacques Delaunay, MD, Noel-Jean Milpied, PhD, Jean-Luc Harousseau, Norbert Ifrah, MD, Didier Blaise, Norbert Vey, MD, Mohamad Mohty, MD, PhD

Blood (2008) 112 (11): 1121.

https://doi.org/10.1182/blood.V112.11.1121.1121

Published: 2008

Journal Articles

Donor Lymphocyte Infusions (DLI) for the Treatment of Disease Relapse in Hematological Malignancies Following Allogeneic Transplantation: Similar Efficacy Following RIC or Myeloablative Regimen

Thierry Guillaume, Patrice Chevallier, Sameh Ayari, Jacques Delaunay, Laurence Lode, Francoise Mechinaud, Hervé Avet-Loiseau, Philippe Moreau, Jean Luc Harousseau, Mohamad Mohty

Blood (2008) 112 (11): 2915.

https://doi.org/10.1182/blood.V112.11.2915.2915

Published: 2008

Journal Articles

Improved Prognosis of Children and Adolescents with Acute Lymphoblastic Leukemia (ALL) and Very-High Minimal Residual Disease (MRD) and the End of Induction therapy (EOI)? Preliminary Results of the FRALLE 2000 Protocol

Jean-Michel Cayuela, Kheira Beldjord, Sylvie Fasola, Marie-Françoise Auclerc, MD, Benoît Brethon, Anne Auvrignon, Francoise Mechinaud, Virginie Gandemer, MD, Geneviève Margueritte, Pascale Blouin, Nathalie Grardel, Hélène Cavé, Elizabeth Macintyre, Leverger Leverger, MD, PhD, Andre Baruchel, MD

Blood (2008) 112 (11): 2541.

https://doi.org/10.1182/blood.V112.11.2541.2541

Published: 2008

Journal Articles

Impact of Conditionning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Children with Acute Myeloid Leukemia in First Complete Remission: Total-Body Irradiation and Cyclophosphamide Versus Busulfan and Cyclophosphamide - A Report from The Societe Francaise de Greffe de Moelle et de Therapie Cellulaire.

Jean-Hugues Dalle, MD, PhD, Luc Caty, MD, Regis Peffault, MD, Alexandra Salmon, MD, Valerie Mialou, MD, Claire Galambrun, MD, Karima Yakouben, MD, Francoise Mechinaud, MD, Pierre Bordigoni, MD

Blood (2007) 110 (11): 617.

https://doi.org/10.1182/blood.V110.11.617.617

Published: 2007

Journal Articles

SFCE (Societe Francaise des Cancers de l’Enfant) Recommendations for the Management of Tumor Lysis Syndrome (TLS): A Validation Survey.

Yves Bertrand, Anne Auvrignon, MD, Brigitte Nelken, MD, Valérie Mialoux, MD, Francoise Mechinaud, MD, Catherine Patte, MD, Dominique Plantaz, MD, Nathalie Le Guyader, MD, Marisol Urbieta, MD, Yves Perel, Andre Baruchel9, Guy Leverger

Blood (2005) 106 (11): 3122.

https://doi.org/10.1182/blood.V106.11.3122.3122

Published: 2005

Journal Articles

Emergence of Mucormycosis in Onco-Hematology after Prolonged Use of Voriconazole: Attention Required.

Stephane Vigouroux, MD, Odile Morin, Philippe Moreau, MD, Francoise Mechinaud, MD, Jean-Luc Harousseau, MD, Noel Milpied, MD

Blood (2004) 104 (11): 5061.

https://doi.org/10.1182/blood.V104.11.5061.5061

Published: 2004

NARROW

Imatinib in Children with Chronic Myeloid Leukemia in Chronic Phase: Long-Term Results of the French National Phase IV Trial

Clinical Predictors of Venous Thromboembolism during Therapy for Childhood Acute Lymphoblastic Leukemia

Analysis of a Global Registration Trial of the Efficacy and Safety of CTL019 in Pediatric and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)

Building a Targeted Approach to Assess Risk of Anthracycline Induced Cardiomyopathy Amongst Paediatric Cancer Patients

Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study

Outcomes After a Sequential Clofarabine/Arac-C Chemotherapy Followed By Reduced-Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (allo-SCT) In Pediatrics Patients With JMML Or Primary/Relapsed Refractory AML: A Pilot Study

Interim Report of a Randomized, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Decitabine As an Epigenetic Priming Agent When Combined with Induction Chemotherapy in Pediatric Patients (pts) with Newly Diagnosed Acute Myelogenous Leukemia (AML)

Daunorubicin or Not During the Induction Treatment of Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): The Randomized Fralle 2000-A Protocol

Dasatinib In Children and Adolescents with Relapsed or Refractory Leukemia: Results of the CA180018 Phase 1 Dose-Escalation Study of the Innovative Therapies for Children with Cancer (ITCC) Consortium

Reduced-Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT) In Pediatric Patients Ineligible for Standard Myeloablative Conditioning.

Infectious Complications After Unrelated Umbilical Cord Blood Transplantation (UCBT) in Adult Patients with Hematological Malignancies.

Excellent Prognosis of Children with ETV6-RUNX1 Positive (+) Acute Lymphoblastic Leukemia (ALL) in the FRALLE 2000 Protocol.

Escalated lymphodepletion Followed by Donor Lymphocyte Infusion (DLI) can Induce a Graft-Versus-Host Response without Overwhelming Toxicity.

Dasatinib in Children and Adolescents with Relapsed or Refractory Leukemia: Interim Results of the CA180-018 Phase I Study from the ITCC Consortium.

Prior Treatment with Chemotherapy Associated to Gemtuzumab Ozogamicin (GO) Does Not Increase the Risk of Veno-Occlusive Disease (VOD) after Allogeneic Stem Cell Transplantation (all-SCT).

Donor Lymphocyte Infusions (DLI) for the Treatment of Disease Relapse in Hematological Malignancies Following Allogeneic Transplantation: Similar Efficacy Following RIC or Myeloablative Regimen

Improved Prognosis of Children and Adolescents with Acute Lymphoblastic Leukemia (ALL) and Very-High Minimal Residual Disease (MRD) and the End of Induction therapy (EOI)? Preliminary Results of the FRALLE 2000 Protocol

SFCE (Societe Francaise des Cancers de l’Enfant) Recommendations for the Management of Tumor Lysis Syndrome (TLS): A Validation Survey.

Emergence of Mucormycosis in Onco-Hematology after Prolonged Use of Voriconazole: Attention Required.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only